Synairgen plc (LON:SNG – Get Free Report) shares passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 5.29 ($0.07) and traded as high as GBX 7.59 ($0.09). Synairgen shares last traded at GBX 6.50 ($0.08), with a volume of 98,403 shares changing hands.
Synairgen Trading Up 2.5 %
The company has a current ratio of 6.77, a quick ratio of 6.35 and a debt-to-equity ratio of 0.09. The stock has a market capitalization of £12.99 million, a price-to-earnings ratio of -140.00 and a beta of -2.23. The firm has a 50-day moving average of GBX 5.30 and a 200 day moving average of GBX 6.21.
About Synairgen
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
Further Reading
- Five stocks we like better than Synairgen
- Utilities Stocks Explained – How and Why to Invest in Utilities
- United Airlines Soars on Earnings Beat
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.
